LPX Lipoxen

TIDMLPX

RNS Number : 8984Z

Lipoxen PLC

21 January 2011

Lipoxen plc

("Lipoxen" or the "Company")

Director dealings

The Company was informed on 20 January 2011 that FDS Pharma Ass and Related Parties disposed of 925,000 ordinary shares of 0.5p each ("Ordinary Shares") over 16 separate trades at an average price of 11.23 pence between 16 November and 13 December 2010.

Following these disposals FDS Pharma Ass and Related Parties have an interest in Lipoxen of 41,440,059 Ordinary Shares representing 23.38 per cent of the issued Ordinary Share capital in the Company.

Enquires:

 
 Lipoxen plc                                       +44 (0)20 7389 5015 
 M. Scott Maguire, Chief Executive 
  Officer 
 
 Singer Capital Markets (nominated 
  adviser)                                         +44 (0)20 3205 7500 
 Jeff Keating / Claes Spang 
 
 Walbrook PR Ltd                                   +44 (0)20 7933 8780 
 Bob Huxford (Media Enquiries)                      Mob: 07747 653 908 
                                            bob.huxford@walbrookpr.com 
 Paul Cornelius (Investor Enquiries)                Mob: 07866 384 707 
                                         paul.cornelius@walbrookir.com 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSMMGZMFMNGMZM

Lipoxen (LSE:LPX)
Historical Stock Chart
From Apr 2024 to May 2024

Lipoxen (LSE:LPX)
Historical Stock Chart
From May 2023 to May 2024